TABLE 1.
Strain, plasmid, or bacteriophage | Descriptiona | Reference or source |
---|---|---|
E. coli | ||
260-1 | LT CFA/III | 12 |
31-10 | LT CFA/III | 13 |
31-10P | CFA/III-negative spontaneous derivative of strain 31-10; LT | This study |
HB101 | Host for recombinant plasmids | Laboratory stock |
JM109 | Host for recombinant M13 bacteriophages | Laboratory stock |
Plasmid | ||
pSH1134 | 32.5-kb plasmid containing CFA/III gene cluster and Tn3 insertion; Apr | 32 |
pTT201 | pMW119 (AccI and BamHI sites) containing 8.6-kb ClaI1-BamHI1 fragment from pTT202; Apr | 40 |
pTT202 | pMW119 (AccI site) containing 11.5-kb ClaI1-ClaI2 fragment from pSH1134; Apr | 32, 40 |
pTT206 | pACYC184 (BamHI site) containing 12.4-kb BamHI1-BamHI2 fragment from pSH1134; Cmr | 32, 41 |
pTT222 | pACYC184 (EcoRI site) containing 5.2-kb EcoRI2-EcoRI3 fragment from pTT206; Tcr | 41 |
pTT224 | pACYC184 (SalI and BamHI sites) containing 7.6-kb SalI4-BamHI2 fragment from pTT206; Tcr | 41 |
pTT237 | pMW119 (KpnI and AccI sites) containing 9.0-kb KpnI-ClaI2 fragment from pTT202; Apr | This study |
pMW119 | Cloning vector; AprlacZ | Nippon Gene |
pACYC184 | Cloning vector; Cmr Tcr | Nippon Gene |
Bacteriophage | ||
M13mp18 | Cloning vector; lacZ | Laboratory stock |
M13mp19 | Cloning vector; lacZ | Laboratory stock |
Apr, Cmr, and Tcr, ampicillin, chloramphenicol, and tetracycline resistance, respectively.